Newsroom

Categories: Omics & Genetics, Biotechnology, Corporate, Finance & Investor

NGI becomes first certified core lab and service provider for Epigenica’s EpiFinder™ platforms

May 19, 2026

Categories: Omics & Genetics, Clinical Research & Trials, Corporate, Finance & Investor

Biognosys Group announces collaboration with The Michael J. Fox Foundation to advance Parkinson’s disease research through the development of improved biomarker assays

April 14, 2026

Categories: Omics & Genetics, Biotechnology, Corporate, Finance & Investor

Plasmidsaurus accelerates RNA-Seq: New EU hub and Genovis partnership adds stability to speed, without the ice

April 2, 2026

Categories: Omics & Genetics, Biotechnology, Corporate, Finance & Investor

Epigenica AB Expands presence in Japan through distribution agreement with PrimeTech

March 19, 2026

Categories: Omics & Genetics, Biotechnology, Corporate, Finance & Investor

University of Colorado grants license to Cirena for RNA-synthesis technology

March 10, 2026

Categories: Omics & Genetics, Biotechnology

Epigenica AB launches EpiFinder™ cNUC: The first platform to simultaneously profile multiple histone marks and DNA methylation directly from circulating nucleosomes in plasma and serum

February 25, 2026

Categories: Omics & Genetics, Clinical Research & Trials, Corporate, Finance & Investor

Cirena launches high-purity long RNA to accelerate CRISPR and genome-editing research

February 3, 2026

Categories: Bioprocessing, Omics & Genetics, Research

Epigenica launches EpiFinder™ Analysis Service, a fully managed platform for fast and reliable epigenomic insights

January 27, 2026

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, Pharma, Clinical Research & Trials

EpiCypher launches Fiber-seq, a breakthrough multiomic single-molecule genomics assay

September 3, 2025